» 
Strengthening the team
Copy URL
https://www.pharmnovo.com/post/pharmnovo-strengthens-the-team

Strengthening the team

October 11, 2022

PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical trial manager to continue the development of the company's drug candidate PN6047 for the treatment of neuropathic pain, so-called nerve pain.

Inge Tarnow joins the team as the new Senior project manager and will lead and coordinate the work with PN6047. Inge Tarnow holds a Ph.D. in pathophysiology and is a Doctor of Veterinary Medicine. She has worked as a project manager at Savara, a biopharmaceutical company focusing on rare respiratory diseases, for six years.

PharmNovo also welcomes Thomas Eskildsen, Senior Clinical Trial Manager. He will oversee the phase I study while being an asset to the team in the planning and managing future phase IIa studies.

Pressrelease

LinkedIn

Petra Larson
Author:
Petra Larson

Latest news

View all
December 22, 2022

PharmNovo at Biostock

CEO Per von Mentzer presented PharmNovo at the BioStock - Connecting Innovation and Capital Life Science Fall Summit 2022. Watch his presentation addressing the large, unmet medical needs in the neuropathic pain market and learn more about our ongoing clinical trial and how we will achieve project milestones as PharmNovo moves forward.

Read more
December 22, 2022

Seasons Greetings 2022

The PharmNovo team would like to wish you a Merry Christmas and a Happy New Year!

Read more
September 20, 2022

Good press in SvD

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

Read more
September 5, 2022

OP Team steps up

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

Read more

By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Awesome 👌
← Back
No items found.
October 11, 2022

Strengthening the team

PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical trial manager to continue the development of the company's drug candidate PN6047 for the treatment of neuropathic pain, so-called nerve pain.

Inge Tarnow joins the team as the new Senior project manager and will lead and coordinate the work with PN6047. Inge Tarnow holds a Ph.D. in pathophysiology and is a Doctor of Veterinary Medicine. She has worked as a project manager at Savara, a biopharmaceutical company focusing on rare respiratory diseases, for six years.

PharmNovo also welcomes Thomas Eskildsen, Senior Clinical Trial Manager. He will oversee the phase I study while being an asset to the team in the planning and managing future phase IIa studies.

Pressrelease

LinkedIn

October 11, 2022

Strengthening the team

PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical trial manager to continue the development of the company's drug candidate PN6047 for the treatment of neuropathic pain, so-called nerve pain.

Inge Tarnow joins the team as the new Senior project manager and will lead and coordinate the work with PN6047. Inge Tarnow holds a Ph.D. in pathophysiology and is a Doctor of Veterinary Medicine. She has worked as a project manager at Savara, a biopharmaceutical company focusing on rare respiratory diseases, for six years.

PharmNovo also welcomes Thomas Eskildsen, Senior Clinical Trial Manager. He will oversee the phase I study while being an asset to the team in the planning and managing future phase IIa studies.

Pressrelease

LinkedIn

Author:

Petra Larson

Author:

Petra Larson

PharmNovo at Biostock

CEO Per von Mentzer presented PharmNovo at the BioStock - Connecting Innovation and Capital Life Science Fall Summit 2022. Watch his presentation addressing the large, unmet medical needs in the neuropathic pain market and learn more about our ongoing clinical trial and how we will achieve project milestones as PharmNovo moves forward.

Read more →

Seasons Greetings 2022

The PharmNovo team would like to wish you a Merry Christmas and a Happy New Year!

Read more →

Good press in SvD

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

Read more →

OP Team steps up

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

Read more →
Latest
breaking
news

Find us

PharmNovo AB
Medicon Village AB
Scheeletorget 1
SE-223 81 Lund, Sweden

Map